FOSUN HEALTH Logo

Kidney Cancer Prevention

catalogue

Kidney Cancer Prevention

Kidney Cancer Prevention

Kidney cancer sits in an unusual position: its risk factors are among the clearest of any solid tumour, and there is still no screening programme that finds it early in the general population. That combination is not a contradiction. The factors that can be changed are known and worth changing, while the test that would be needed for screening — regular scanning of healthy people — is neither practical nor proven to reduce deaths. What actually detects this cancer early is something less tidy: imaging performed for another reason.

Why there is no screening programme

The absence of a screening programme is a considered position, not an oversight, and the reasons are worth setting out because patients reasonably ask why a cancer with known risk factors is not screened for:

  • Scanning healthy people finds things that do not matter. Imaging of the abdomen in adults without symptoms regularly reveals small masses that would never have caused harm, and each one triggers investigation, anxiety and often treatment that was not needed.
  • It is not uncommon enough, or common enough. Screening works best for conditions that are frequent and have a long silent period detectable by a simple test; kidney cancer does not fit that profile well.
  • There is no simple, sensitive first-line test. Urine testing does not detect most kidney tumours, and blood tests are not specific — so effective screening would require imaging, which is expensive and carries its own findings.
  • No trial has demonstrated a reduction in deaths from screening. Without that, recommending it would expose many people to investigation for a benefit that has not been shown.

That is a statement about the general population, and there are two clearly bounded exceptions. Patients with an inherited syndrome such as von Hippel-Lindau disease are placed on a surveillance programme, because their risk is high enough and the pattern of disease defined enough to justify it. Patients on long-term dialysis, particularly with acquired cystic disease of the kidney, are likewise followed with regular imaging. Both are surveillance rather than screening — they apply to people whose risk is already known to be substantially higher.

Stopping smoking

Smoking is the best established modifiable factor and therefore the most useful target. The relationship is cumulative — risk rises with the number of cigarettes and the number of years — which means that stopping reduces further accrual of risk without erasing what has already happened.

Three points keep this honest:

  • Stopping is worthwhile at any age. The reduction is real, and it accumulates the longer a person remains an ex-smoker.
  • It does not return the risk to that of a never-smoker. A smoking history remains relevant information for the rest of a patient’s life, including in the assessment of a kidney mass found years later.
  • It is not the only factor, and not a guarantee. A substantial number of patients have never smoked, which is a reason not to treat a clean history as a reason to ignore a finding on a scan.

If the aim is to stop smoking, the practical advice is to use the support that exists rather than relying on willpower alone — the counselling, prescriptions and support services that reduce the risk of lung and bladder disease apply here too, and behavioural support combined with medication works better than either on its own. The same route that lowers cardiovascular risk also lowers kidney cancer risk, which is a useful way to think about it.

Body weight and blood pressure

The second and third established factors are related to each other but act independently, and both are modified by the same set of measures: physical activity, dietary pattern and, where needed, medication.

  • Body weight — risk rises steadily as body mass index rises, without a threshold below which it stops mattering. Reducing excess weight, and carrying it for fewer years, is associated with lower risk. The evidence does not support weight loss as a guaranteed means of prevention, because other factors are also at work.
  • Blood pressure — higher pressure and longer duration are associated with higher risk, independently of weight. Controlling pressure is worthwhile, and it does not require stopping medication to achieve: the evidence indicates that the underlying high blood pressure is the relevant factor, not the drugs used to treat it.

There is a specific reason for emphasising blood pressure control in this disease rather than treating it as general health advice. If a kidney tumour is found and part of a kidney has to be removed, blood pressure has to be controlled in any case to protect what remains; and some systemic treatments raise blood pressure as a side effect that has to be managed. Someone whose pressure is already well controlled starts from a better position in that situation, and the measures are the same either way.

Protecting kidney function

This is not prevention of cancer, but it belongs in the same conversation because kidney function is what determines what treatment is possible if a tumour is ever found — and because preserving it is largely within a patient’s control.

  • Control blood pressure and blood sugar. Diabetes and hypertension are the two commonest causes of chronic kidney disease, and both are modifiable.
  • Review medicines that stress the kidney. Some painkillers taken regularly over long periods, and certain combinations of drugs used for blood pressure, can reduce kidney function; this is a reason for an annual review rather than a reason to stop anything unilaterally.
  • Stay adequately hydrated during illness. Dehydration during a severe illness puts strain on the kidneys, and recovering what was lost matters more than any specific fluid target.
  • Know your numbers. Creatinine and estimated filtration rate are cheap, routine and worth recording in a place you can find again.

The reason for raising this in a guide to kidney cancer is direct. If a tumour is found, the choice between preserving and removing the kidney may depend on how much function there is to work with, and the assessment asks how the kidneys have been treated over the preceding years. Someone whose creatinine has been stable has more options than someone whose has not — and that is something to work on long before any scan.

What prevention can and cannot do

A few honest statements are needed, because prevention advice in this disease is easy to overstate in both directions:

  • Neither smoking nor weight nor blood pressure explains every case. A substantial share of patients have none of these factors, which is why the disease cannot be prevented away.
  • No diet, supplement or lifestyle measure has been shown to prevent kidney cancer. Attention spent on these tends to displace attention from the factors that have been established.
  • There is no self-referral test worth doing. Regular urine testing does not detect most kidney tumours, and periodic private scanning of people without symptoms finds harmless abnormalities as often as it finds anything useful.
  • Where a condition requires surveillance, that is different. Inherited syndromes and long-term dialysis both place patients in a defined programme, and those programmes should be kept to.

What does that leave? Three things with genuine value: act on the factors you can change, keep the surveillance that your condition warrants, and treat a mass found on any scan as something to be assessed rather than shelved. The third is worth underlining, because it is how most kidney tumours are actually caught — not by a screening programme, and not by waiting for a symptom, but by an imaging test done for another reason being read properly.

Follow-up, and having it written down

For patients who have been treated for kidney cancer, the emphasis shifts from prevention to surveillance, and the schedule depends on the features of the tumour that was removed rather than on a single rule.

  • Imaging on a defined interval — scans of the chest and abdomen at intervals over the first few years, then less often; the interval and duration are set by the stage and grade of the tumour.
  • Kidney function monitored — creatinine and estimated filtration rate checked periodically, because preserving what remains is an ongoing objective rather than a postoperative formality.
  • Blood pressure reviewed — particularly if a systemic treatment known to raise pressure has been used, or is being used.
  • The surveillance document itself — which scans, at which intervals, for how many years, and which symptoms would prompt an earlier appointment.

Two practical points make this work. Because most patients arrange follow-up partly at home and partly with the treating centre, the schedule should be agreed in writing before the first journey home rather than reconstructed later. And because surveillance exists precisely because symptoms are a late and unreliable signal in this disease, the schedule should be presented as a plan rather than a precaution — which is what turns it from something patients feel they can skip into something they keep to.

Frequently Asked Questions

Should I be screened for kidney cancer?

For people without symptoms and without a specific high-risk condition, no — there is no recommended screening programme, because scanning healthy adults finds small masses that would never have caused harm without evidence that it saves lives. Two groups are different and are placed on surveillance rather than screened: patients with an inherited syndrome such as von Hippel-Lindau disease, and patients on long-term dialysis, particularly where acquired cystic disease of the kidney is present. If you are not in either group, the useful actions are to address the risk factors that can be changed and to have any kidney mass found on a scan properly assessed rather than filed away.

Will losing weight or lowering my blood pressure prevent this cancer?

They lower the associated risk, but neither is a guarantee. Body weight and blood pressure are two of the three established risk factors, and both are graded rather than threshold-based, so reducing excess weight and controlling pressure reduce a risk that rises with the degree and duration of each. Risk also depends on age, sex, smoking and factors that cannot be changed, and a substantial proportion of patients have none of these risk factors at all. The honest summary is that these measures reduce risk and are worth taking, and that a normal weight and normal blood pressure are not a reason to dismiss a finding on a scan.

Does regular urine testing detect kidney cancer early?

Not reliably. Blood in the urine is the commonest symptom of kidney cancer, but it is absent in most patients when they are diagnosed, and many tumours never bleed at all. Urine testing is useful for the bladder lining and for detecting blood that needs investigating, and it does play a role in assessment when blood is found. It is not a screening test for the kidney itself, which is why most kidney tumours are found on scans performed for unrelated reasons rather than through urine testing. A normal urine result does not exclude a mass sitting inside the kidney.

What is the follow-up after treatment?

Scans of the chest and abdomen at defined intervals over the first few years, with the interval and the total duration set by the stage and grade of the tumour that was removed rather than by a single rule for everyone. Kidney function is checked periodically, because preserving what remains is an ongoing objective, and blood pressure is reviewed, particularly if a systemic treatment that raises pressure has been used. The most useful thing to ask for is the schedule in writing — which scans, at which intervals, for how many years — because follow-up is often shared between the treating centre and a local hospital, and a written plan is what keeps it intact.

Keep the surveillance plan in writing

Sending the pathology report with the subtype and grade, the operative note, the most recent scan images and your current creatinine allows a written surveillance schedule to be prepared before you travel home, with intervals and duration set by your own tumour.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*